IGC PHARMA, INC. Proceeds from Long-Term Debt Issued
IGC PHARMA, INC. (IGC) reported Proceeds from Long-Term Debt Issued of $623.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-05-15
- IGC PHARMA, INC. proceeds from issuance of long-term debt for the quarter ending 2026-03-31 was $623.00K.
- IGC PHARMA, INC. proceeds from issuance of long-term debt for the quarter ending 2025-03-31 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month |
|---|---|
| 2026-03-31 | $623.00K 10-Q · filed 2026-05-15 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |